Krüppel-like Factor 4 Suppresses Serine/Threonine Kinase 33 Activation and Metastasis of Gastric Cancer through Reversing Epithelial–Mesenchymal Transition
- 14 May 2018
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 24 (10) , 2440-2451
Abstract
Background: Cancers with aberrant expression of Serine/threonine kinase 33 (STK33) has been reported to be particularly aggressive. However, its expression, clinical significance, and biological functions in gastric cancer remain largely unknown. In the present study, we determined the expression and function of STK33 in gastric cancer and delineated the clinical significance of the Krüppel-like factor 4 (KLF4)/STK33 signaling pathway. Methods: STK33 expression and its association with multiple clinicopathologic characteristics were analyzed immunohistochemically in human gastric cancer specimens. STK33 knockdown and overexpression were used to dissect the underlying mechanism of its functions in gastric cancer cells. Regulation and underlying mechanisms of STK33 expression by KLF4 in gastric cancer cells were studied using cell and molecular biological methods. Results: Drastically higher expression of STK33 was observed in gastric cancer and gastric intraepithelial neoplasia tissues compared with adjacent normal gastric tissues. Increased STK33 expression correlated directly with tumor size, lymph node, and distant metastasis; and patients with low STK33 expression gastric cancer were predicted to have a favorable prognosis. Enforced expression of STK33 promoted gastric cancer cell proliferation, migration, and invasion in vitro and in vivo, whereas reduced STK33 did the opposite. Moreover, STK33 promoted epithelial–mesenchymal transition (EMT) in vitro. Mechanistically, KLF4 transcriptionally inhibited STK33 expression in gastric cancer cells. KLF4-mediated inhibition of gastric cancer cell invasion was reversed by upregulation of STK33 expression. Conclusions: STK33 has pro-tumor function and is a critical downstream mediator of KLF4 in gastric cancer. STK33 may serve as a potential prognostic marker and therapeutic target for gastric cancer. Clin Cancer Res; 24(10); 2440–51. ©2018 AACR.Keywords
All Related Versions
Funding Information
- National Cancer Institute National Institutes of Health (R01CA172233, R01CA195651, R01CA198090)
- NSFC (81772640)
This publication has 34 references indexed in Scilit:
- Klf4 Is a Transcriptional Regulator of Genes Critical for EMT, Including Jnk1 (Mapk8)PLOS ONE, 2013
- Krüppel-Like Factor 4, a Tumor Suppressor in Hepatocellular Carcinoma Cells Reverts Epithelial Mesenchymal Transition by Suppressing Slug ExpressionPLOS ONE, 2012
- Roles of fibroblasts from the interface zone in invasion, migration, proliferation and apoptosis of gastric adenocarcinomaJournal of Clinical Pathology, 2012
- Targeting of KRAS mutant tumors by HSP90 inhibitors involves degradation of STK33Journal of Experimental Medicine, 2012
- Disruption of Klf4 in Villin-Positive Gastric Progenitor Cells Promotes Formation and Progression of Tumors of the Antrum in MiceGastroenterology, 2012
- STK33 kinase inhibitor BRD-8899 has no effect on KRAS-dependent cancer cell viabilityProceedings of the National Academy of Sciences, 2012
- The Serine/threonine kinase Stk33 exhibits autophosphorylation and phosphorylates the intermediate filament protein VimentinBMC Biochemistry, 2008
- Krüppel-like Factor 4 Induces p27Kip1 Expression in and Suppresses the Growth and Metastasis of Human Pancreatic Cancer CellsCancer Research, 2008
- Differential expression pattern of the novel serine/threonine kinase, STK33, in mice and menThe FEBS Journal, 2005
- Molecular basis of gastric cancer development and progressionGastric Cancer, 2004